1. A study of the mechanism of the hemodynamic effects of hydralazine in man;Ablad, B.;Acta Pharmacologica et Toxicologica,1963
2. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation;Bolen, J.L.; Alderman, E.L.;Circulation,1976
3. Chatterjee, K., Parmley, W. W., Ganz, W., Forrester, J., Walinsky, P., Crexells, C., and Swan, H. J. C. (1973a).
4. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus;Chatterjee, K.; Parmley, W.W.; Swan, H.J.C.; Berman, G.; Forrester, J.; Marcus, H.S.;Circulation,1973
5. Oral hydralazine therapy for chronic refractory heart failure;Chatterjee, K.; Parmley, W.W.; Massie, B.; Greenberg, B.; Werner, J.; Klausner, S.; Norman, A.;Circulation,1976